Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Mason

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
Histology and Histopathology|September 2, 2005
Hepatocyte growth factor/scatter factor and prostate cancer: a reviewR A Hurle, G Davies, C Parr, et al.
British Journal of Cancer|September 1, 1995
High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer: poor response rate in unselected patientsC L Hanna, F E McKinna, L B Williams, et al.
Journal of Immunological Methods|January 11, 2001
Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometryA Clayton, J Court, H Navabi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 2, 2016
High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical PracticeJ S Tanguay, C Catlow, C Smith, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 27, 2000
Randomized trials in early prostate cancer. II: hormone therapy and radiotherapy for locally advanced disease: a question is still unanswered. MRC PR07 Trial Management GroupM D Mason, S Brewster, L E Moffat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 11, 2001
Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment aloneH Patterson, A R Norman, S S Mitra, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 19, 2016
Radiotherapy for Prostate Cancer: is it 'what you do' or 'the way that you do it'? A UK Perspective on Technique and Quality AssuranceM D Mason, R Moore, G Jones, et al.
Blood Cells, Molecules & Diseases|August 3, 2005
Preparation of human ovarian cancer ascites-derived exosomes for a clinical trialH Navabi, D Croston, J Hobot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1994
A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancerP M Quilty, D Kirk, J J Bolger, et al.
Seminars in Oncology|June 1, 1993
Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators GroupJ J Bolger, D P Dearnaley, D Kirk, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
Histology and Histopathology|September 2, 2005
Hepatocyte growth factor/scatter factor and prostate cancer: a reviewR A Hurle, G Davies, C Parr, et al.
British Journal of Cancer|September 1, 1995
High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer: poor response rate in unselected patientsC L Hanna, F E McKinna, L B Williams, et al.
Journal of Immunological Methods|January 11, 2001
Analysis of antigen presenting cell derived exosomes, based on immuno-magnetic isolation and flow cytometryA Clayton, J Court, H Navabi, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 2, 2016
High Risk of Neutropenia for Hormone-naive Prostate Cancer Patients Receiving STAMPEDE-style Upfront Docetaxel Chemotherapy in Usual Clinical PracticeJ S Tanguay, C Catlow, C Smith, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|September 27, 2000
Randomized trials in early prostate cancer. II: hormone therapy and radiotherapy for locally advanced disease: a question is still unanswered. MRC PR07 Trial Management GroupM D Mason, S Brewster, L E Moffat, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 11, 2001
Combination carboplatin and radiotherapy in the management of stage II testicular seminoma: comparison with radiotherapy treatment aloneH Patterson, A R Norman, S S Mitra, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 19, 2016
Radiotherapy for Prostate Cancer: is it 'what you do' or 'the way that you do it'? A UK Perspective on Technique and Quality AssuranceM D Mason, R Moore, G Jones, et al.
Blood Cells, Molecules & Diseases|August 3, 2005
Preparation of human ovarian cancer ascites-derived exosomes for a clinical trialH Navabi, D Croston, J Hobot, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 1, 1994
A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancerP M Quilty, D Kirk, J J Bolger, et al.
Seminars in Oncology|June 1, 1993
Strontium-89 (Metastron) versus external beam radiotherapy in patients with painful bone metastases secondary to prostatic cancer: preliminary report of a multicenter trial. UK Metastron Investigators GroupJ J Bolger, D P Dearnaley, D Kirk, et al.
Pageof 9